-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.008.17% Upside
Amneal Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler, Truist Financial, Goldman Sachs in the past 90 days.